Insulin Tactics in Type 2 Diabetes

Farah Meah, Rattan Juneja

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Type 2 diabetes is a heterogeneous disorder with multiple pathophysiologic defects resulting in an inability to maintain euglycemia. When exogenous insulin is used in its treatment, it is important to take into account its pharmacokinetic properties and attempt to match its peaks and troughs with those of glucose. In this article, the authors discuss strategies on introducing insulin as a treatment option in patients with Type 2 diabetes and how to decrease it when other noninsulin drugs are added to the treatment regimen.

Original languageEnglish
Pages (from-to)157-186
Number of pages30
JournalMedical Clinics of North America
Volume99
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Type 2 Diabetes Mellitus
Insulin
Therapeutics
Pharmacokinetics
Glucose
Pharmaceutical Preparations

Keywords

  • Exogenous insulin profiles
  • Insulin adjustment
  • Insulin administration
  • Insulin secretion
  • Noninsulin therapy
  • Type 2 diabetes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Insulin Tactics in Type 2 Diabetes. / Meah, Farah; Juneja, Rattan.

In: Medical Clinics of North America, Vol. 99, No. 1, 01.01.2015, p. 157-186.

Research output: Contribution to journalArticle

Meah, Farah ; Juneja, Rattan. / Insulin Tactics in Type 2 Diabetes. In: Medical Clinics of North America. 2015 ; Vol. 99, No. 1. pp. 157-186.
@article{f63ac7fdf1094cb3a6748429d902b47b,
title = "Insulin Tactics in Type 2 Diabetes",
abstract = "Type 2 diabetes is a heterogeneous disorder with multiple pathophysiologic defects resulting in an inability to maintain euglycemia. When exogenous insulin is used in its treatment, it is important to take into account its pharmacokinetic properties and attempt to match its peaks and troughs with those of glucose. In this article, the authors discuss strategies on introducing insulin as a treatment option in patients with Type 2 diabetes and how to decrease it when other noninsulin drugs are added to the treatment regimen.",
keywords = "Exogenous insulin profiles, Insulin adjustment, Insulin administration, Insulin secretion, Noninsulin therapy, Type 2 diabetes",
author = "Farah Meah and Rattan Juneja",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.mcna.2014.08.021",
language = "English",
volume = "99",
pages = "157--186",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Insulin Tactics in Type 2 Diabetes

AU - Meah, Farah

AU - Juneja, Rattan

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Type 2 diabetes is a heterogeneous disorder with multiple pathophysiologic defects resulting in an inability to maintain euglycemia. When exogenous insulin is used in its treatment, it is important to take into account its pharmacokinetic properties and attempt to match its peaks and troughs with those of glucose. In this article, the authors discuss strategies on introducing insulin as a treatment option in patients with Type 2 diabetes and how to decrease it when other noninsulin drugs are added to the treatment regimen.

AB - Type 2 diabetes is a heterogeneous disorder with multiple pathophysiologic defects resulting in an inability to maintain euglycemia. When exogenous insulin is used in its treatment, it is important to take into account its pharmacokinetic properties and attempt to match its peaks and troughs with those of glucose. In this article, the authors discuss strategies on introducing insulin as a treatment option in patients with Type 2 diabetes and how to decrease it when other noninsulin drugs are added to the treatment regimen.

KW - Exogenous insulin profiles

KW - Insulin adjustment

KW - Insulin administration

KW - Insulin secretion

KW - Noninsulin therapy

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84914181604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84914181604&partnerID=8YFLogxK

U2 - 10.1016/j.mcna.2014.08.021

DO - 10.1016/j.mcna.2014.08.021

M3 - Article

VL - 99

SP - 157

EP - 186

JO - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

IS - 1

ER -